ArticleCommunications biology2025
ViTrace detects viral signatures in tumor transcriptomes using a hybrid language model.
Article in Communications biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- ViTrace detects viral signatures in tumor transcriptomes using a hybrid language model.Communications biology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Identifying viruses in tumor transcriptome helps to unravel the potential role of viruses in oncogenesis and tumor progression. Most of the current tools for virus identification in RNA-Seq data rely on sequence alignment, whose performance is constrained by fast mutations, large divergence, and the incompleteness of viral genomes. In this study, we develop ViTrace to detect viral sequences in human transcriptomic data by a hybrid language representation learning model, which integrates DNA contexts, position relationships and amino acid coding information. Although ViTrace is only trained on 13 species from 7 genera, it achieves 86.39% recall in 1179 absent-in-train virus strains of 935 species belonging to 167 genera across 10 phyla. Applied to single-cell RNA-seq data from esophageal and oropharyngeal squamous cell carcinomas, the model reveals tumor-, cell-, and patient-specific viral colonization patterns, uncovering both known and previously unreported viruses. Overall, ViTrace provides a scalable framework for guiding precision oncology and facilitating future discoveries of previously uncharacterized tumor-associated viruses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.